Clarke Christopher J, Guthrie J Michael, Hannun Yusuf A
Department of Biochemistry and Molecular Biology, 173 Ashley Ave, Charleston, SC 29425, USA.
Mol Pharmacol. 2008 Oct;74(4):1022-32. doi: 10.1124/mol.108.046250. Epub 2008 Jul 24.
Neutral sphingomyelinases (N-SMases) are major candidates for stress-induced ceramide production, but there is still limited knowledge of the regulatory mechanisms of the cloned N-SMase enzyme-nSMase2. We have reported that p38 mitogen-activated protein kinase (MAPK) was upstream of nSMase2 in tumor necrosis-alpha (TNF-alpha)-stimulated A549 cells ( J Biol Chem 282: 1384-1396, 2007 ). Here, we report a role for protein kinase C (PKC) in mediating TNF-induced translocation of nSMase2 from the Golgi to the plasma membrane (PM). Pharmacological inhibition of PKCs prevented TNF-stimulated nSMase2 translocation to the PM in A549 cells. Using phorbol 12-myristate 13-acetate (PMA) as a tool to dissect PKC responses, we found that PMA induced nSMase2 translocation to the PM in a time- and dose-dependent manner. Pharmacological inhibitors and specific siRNA implicated the novel PKCs, specifically PKC-delta, in both TNF and PMA-stimulated nSMase2 translocation. However, PMA did not increase in vitro N-SMase activity and PKC-delta did not regulate TNF-induced N-SMase activity. Furthermore, PKC-delta and nSMase2 did not coimmunoprecipitate, suggesting that other signaling proteins may be involved. PMA-stimulated nSMase2 translocation was independent of p38 MAPK, and neither PKC inhibitors nor small interfering RNA had significant effects on TNF-stimulated p38 MAPK activation, indicating that PKC-delta does not act through p38 MAPK in regulating nSMase2. Finally, down-regulation of PKC-delta inhibited induction of vascular cell and intercellular adhesion molecules, previously identified as downstream of nSMase2 in A549 cells. Taken together, these data implicate PKC-delta as a regulator of nSMase2 and, for the first time, identify nSMase2 as a point of cross-talk between the PKC and sphingolipid pathways.
中性鞘磷脂酶(N-SMases)是应激诱导神经酰胺产生的主要候选酶,但对于已克隆的N-SMase酶——nSMase2的调控机制仍知之甚少。我们曾报道,在肿瘤坏死因子-α(TNF-α)刺激的A549细胞中,p38丝裂原活化蛋白激酶(MAPK)位于nSMase2的上游(《生物化学杂志》282: 1384 - 1396, 2007)。在此,我们报道蛋白激酶C(PKC)在介导TNF诱导的nSMase2从高尔基体转位至质膜(PM)过程中的作用。PKC的药理学抑制可阻止TNF刺激的nSMase2在A549细胞中转位至质膜。使用佛波酯12 - 肉豆蔻酸酯13 - 乙酸酯(PMA)作为剖析PKC反应的工具,我们发现PMA以时间和剂量依赖的方式诱导nSMase2转位至质膜。药理学抑制剂和特异性小干扰RNA表明,新型PKC,特别是PKC-δ,参与了TNF和PMA刺激的nSMase2转位。然而,PMA并未增加体外N-SMase活性,且PKC-δ并未调节TNF诱导的N-SMase活性。此外,PKC-δ和nSMase2未发生共免疫沉淀,这表明可能涉及其他信号蛋白。PMA刺激的nSMase2转位独立于p38 MAPK,PKC抑制剂和小干扰RNA对TNF刺激的p38 MAPK激活均无显著影响,这表明PKC-δ在调节nSMase2时并非通过p38 MAPK发挥作用。最后,PKC-δ的下调抑制了血管细胞和细胞间黏附分子的诱导,这些分子先前被确定为A549细胞中nSMase2的下游分子。综上所述,这些数据表明PKC-δ是nSMase2的调节因子,并且首次确定nSMase2是PKC和鞘脂途径之间的一个相互作用点。